用于治疗 COVID-19 的抗病毒药物：进展与挑战。
Antiviral agents for the treatment of COVID-19: Progress and challenges.
机构信息
Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.
出版信息
Cell Rep Med. 2022 Feb 11;3(3):100549. doi: 10.1016/j.xcrm.2022.100549. eCollection 2022 Mar 15.
Abstract
The COVID-19 pandemic has seen clinical development and use of antiviral therapies at an unprecedented speed. Antiviral therapies have greatly improved the clinical outcome in COVID-19 patients, especially when administered early after diagnosis. Here, we discuss the successes and challenges of COVID-19 antiviral therapies and lessons for future pandemics.
摘要
新冠疫情以空前的速度推动了抗病毒疗法的临床研发和应用。抗病毒疗法极大地改善了新冠患者的临床结局，尤其是在诊断后早期应用时。在此，我们讨论了新冠抗病毒疗法的成功和挑战，以及对未来大流行的启示。
Zotero 插件